Clinical Trials Logo

Clinical Trial Summary

This is a double-blind, randomized, controlled, parallel design (n=140) study with the purpose of measuring the efficacy of Solifenacin 5mg in the treatment of women with Post Void Dribbling (PVD).


Clinical Trial Description

This investigation will have a double-blind, randomized, and controlled, parallel design with the % reduction in PVD episodes (events) as the primary endpoint.

Secondary endpoints will include:

1. The % of patients with at least a 50% reduction in PVD episodes.

2. Patient's perspective of the impact of their disease, which will be captured using the Pelvic Floor Distress Inventory (PFDI), and another questionnaire that asks about urinary symptoms and quality of life.

We will compare Solifenacin 5 mg to placebo. 140 subjects will be enrolled, with 70 subjects in each arm. The treatment group will receive 5mg of Solifenacin daily for 12 weeks. Astellas Pharma will be supplying both drug and placebo, they will be prepackaged and numbered. The Pharmaceutical Research Center (PRC) will randomly assign subjects into the treatment vs. placebo group blinding both the subjects and investigators ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01470001
Study type Interventional
Source University of Wisconsin, Madison
Contact
Status Completed
Phase N/A
Start date November 2011
Completion date September 2015

See also
  Status Clinical Trial Phase
Completed NCT02835846 - Investigation of the Effect of the Female Urinary Microbiome on Incontinence Phase 4
Recruiting NCT02978638 - Electrical Stimulation for Continence After Spinal Cord Injury N/A
Completed NCT01978210 - Development of a Manualized Wireless Moisture Pager Intervention for Teaching Toileting in Children With Autism N/A
Completed NCT00972998 - Study to Examine the Effect of Coated Phenylephrine Suppositories on Anal Pressure in Healthy Subjects Phase 1/Phase 2
Completed NCT01036035 - Effects of Novel Combinations of Tolterodine/Pilocarpine on Pharmacokinetics (PK) and Pharmacodynamics (PD) of Tolterodine in Healthy Subjects Phase 1
Recruiting NCT04110821 - Quality of Life After Conservative and Surgical Treatment of Pelvic Organ Prolapse
Recruiting NCT05826691 - Benign Prostate Surgery and QOL and Sexual Function
Recruiting NCT05362292 - TReating Incontinence for Underlying Mental and Physical Health Phase 4
Recruiting NCT05935371 - Consequences of Obstetric Anal Sphincter Injuries on Maternal Psychology and Relationship Experience
Completed NCT02554201 - Efficacy of Electrical Pudendal Nerve Stimulation for Neurogenic Lower Urinary Tract Dysfunction N/A
Completed NCT01486706 - Efficacy and Safety of Gabapentin in Treating Overactive Bladder Phase 2/Phase 3
Completed NCT00617786 - CPT Testing for Sacral Neuromodulation Outcomes N/A
Completed NCT02633592 - Seated Evaluation of Anorectal funcTion by High Resolution Anorectal Manometry N/A
Completed NCT01747343 - Toilet Training Toddlers and Preschoolers N/A
Recruiting NCT02091947 - Efficacy of Functional Magnetic Stimulation in Urinary Incontinence Phase 2
Completed NCT01108367 - Transient Urinary Incontinence After Holmium Laser Enucleation of the Prostate (HoLEP) N/A
Completed NCT04924218 - Evaluation of the Effect of Endoscopic Urethral Procedures Applied After Radical Prostatectomy on Urinary Incontinence N/A
Recruiting NCT04010292 - Enhancing Patient Recall in Urogynecologic Surgery N/A
Completed NCT05106010 - The Effect of Yoga on Decreasing Risk of Fall-Related Injury in Peri and Post-Menopausal
Completed NCT04867876 - Qol Following Management for Pediatric UI N/A